Jennifer Morrison Reveals How Her Journey with Migraine is More Than a Headache
25 Avril 2016 - 2:00PM
Business Wire
Actress Shares Her Migraine Experience as Part
of MoreToMigraine.com
Teva Pharmaceutical Industries Ltd. today announced the launch
of More To Migraine, a national campaign aimed at raising awareness
of migraine and all that comes with it. The campaign features
actress and director Jennifer Morrison who is speaking publicly for
the first time about the impact migraine has had on her career and
busy lifestyle.
“Throughout my career I have played many roles, but migraine
sufferer has been the hardest,” said Jennifer Morrison, More To
Migraine spokesperson. “My hope is that by sharing my personal
experience, I can encourage the nearly 36 million Americans who
suffer from migraine to talk to their healthcare provider about how
their migraine impacts them.”
Migraine is more than a headache. The National Institute of
Neurological Disorders and Stroke defines migraine as recurrent
attacks of moderate to severe headache pain that is throbbing or
pulsing, worse with physical activity, and often strikes one side
of the head. These headaches can be accompanied by sensitivity to
light and sound as well as nausea and vomiting. The frequency,
severity and characteristics of migraine vary widely among
individuals and many people with migraine may deny their condition
or feel embarrassed.
“I know firsthand that not all migraines are the same and aren’t
just limited to my head. Talking with my doctor helped me better
understand my migraine characteristics and triggers,” Morrison
said.
MoreToMigraine.com was created to help provide migraine
sufferers with information and resources to help them talk with
their healthcare provider about their individual migraine
experience. The website features:
- Information about migraine triggers and
characteristics including throbbing head pain, nausea, vomiting and
sensitivity to light and sound.
- Resources to help migraine sufferers
talk with their healthcare provider such as Dr. Susan Hutchinson’s
“10 Migraine Tips You Don’t Want to Miss.”
- Personal perspectives from fellow
migraine sufferers like Jennifer Morrison.
Visit MoreToMigraine.com for information and resources for
people suffering from migraine.
Jennifer Morrison and Dr. Susan Hutchinson serve as a paid
spokespeople for Teva Pharmaceuticals.
About Jennifer Morrison
Jennifer Morrison is an American actress, director and migraine
sufferer. She is known for her roles as Emma Swan in the ABC
adventure fantasy series "Once Upon a Time" and Dr. Allison Cameron
in "House M.D.", alongside Hugh Laurie. She also portrayed Zoey
Pierson, one of Ted Mosby's love interests, in "How I Met Your
Mother" and Winona Kirk, mother of James T. Kirk, in "Star Trek."
In 2011, Morrison co-starred alongside Joel Edgerton, Tom Hardy and
Nick Nolte the film “Warrior.”
About Teva
Teva Pharmaceutical Industries Ltd is a leading global
pharmaceutical company that delivers high-quality, patient-centric
healthcare solutions to millions of patients every day. In addition
to being the world’s largest generic medicines producer, Teva has
world-leading positions in multiple specialty medicines therapeutic
areas. In North America, Teva’s Specialty Medicines business
focuses on innovative treatments for disorders of the central
nervous system (CNS), including pain, and respiratory diseases, as
well as having a strong presence in oncology, women’s health and
select, US-only brands. Our focus is on creating new ways of
addressing unmet patient needs, by combining drug development
capabilities with devices, patient services and technologies. For
more information, visit www.tevausa.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160425005195/en/
For Teva Pharmaceutical Industries Ltd.PR Contacts:Nancy
Leone, 215-284-0213Michelle Larkin, 610-786-7335Doris
Saltkill, 913-777-3343
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024